Skip to content

A single-center prospective comparative study of a novel detachable coil cohort and historical traditional coil treatment for pulmonary sequestration

The evaluation of the safety and efficacy of FOC detachable coils in the treatment of Pryce I pulmonary sequestration

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600124876
Enrollment
Unknown
Registered
2026-05-19
Start date
2026-06-01
Completion date
Unknown
Last updated
2026-05-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pulmonary sequestration

Interventions

FOC detachable coil group (prospective group):None
Traditional coil set (retrospective group):None

Sponsors

West China Hospital of Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
14 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. FOC detachable coil group (prospective group): (1) Definitively diagnosed with Pryce type I pulmonary sequestration and intended to undergo interventional embolization therapy; (2) Aged >= 14 years; (3) Imaging clearly demonstrates abnormal systemic blood supply artery; (4) Signed informed consent form. 2. Traditional coil set (retrospective group): (1) The patient has been diagnosed with Pryce type I pulmonary sequestration and has undergone traditional coil interventional embolization therapy; (2) Age >= 14 years old; (3) Complete preoperative and postoperative clinical and radiological data.

Exclusion criteria

Exclusion criteria: Exclusion criteria: 1. Concurrent severe underlying diseases; 2. Allergy to contrast media; 3. Incomplete treatment or loss to follow-up after surgery; 4. Follow-up duration less than 3 months; 5. Other situations where clinicians consider it inappropriate to use FOC detachable coils / perform interventional surgery.

Design outcomes

Primary

MeasureTime frame
Imaging changes;The patient's hemoptysis condition;Success rate of the surgically preset target area;

Secondary

MeasureTime frame
Vital signs (including blood pressure, heart rate, and oxygen saturation measured by pulse oximetry);

Countries

China

Contacts

Public ContactJiang Faming

West China Hospital of Sichuan University

jiangfam@163.com+86 28 8542 2376

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 30, 2026